MARKET

YARW

YARW

YARROW BIOSCIENCE, INC.
NASDAQ
19.87
-0.13
-0.65%
Opening 10:45 10/27 EDT
OPEN
19.95
PREV CLOSE
20.00
HIGH
20.23
LOW
19.33
VOLUME
20.99K
TURNOVER
--
52 WEEK HIGH
46.95
52 WEEK LOW
16.04
MARKET CAP
187.53M
P/E (TTM)
-0.9095
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at YARW last week (1019-1023)?
Weekly Report · 1d ago
Weekly Report: what happened at YARW last week (1012-1016)?
Weekly Report · 10/19 09:00
Weekly Report: what happened at YARW last week (1005-1009)?
Weekly Report · 10/12 09:00
Weekly Report: what happened at YARW last week (0928-1002)?
Weekly Report · 10/05 09:00
Weekly Report: what happened at YARW last week (0921-0925)?
Weekly Report · 09/28 09:00
Weekly Report: what happened at YARW last week (0914-0918)?
Weekly Report · 09/21 09:00
Yarrow Bioscience Announces Underwritten Equity Offering Agreement
TipRanks · 09/14 20:37
Weekly Report: what happened at YARW last week (0907-0911)?
Weekly Report · 09/14 09:00
More
About YARW
Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company is developing YB-101, an anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' Disease (GD) and Thyroid Eye Disease (TED), offering a single targeted treatment to address both diseases. By blocking TSHR, the common target of autoantibodies in both the thyroid and the eye, YB-101 has the potential to rapidly arrest the disease process and provide improved efficacy and safety versus the standard of care and other mechanisms in development. YB-101 is designed for convenient subcutaneous administration, with the potential for infrequent dosing and future autoinjector presentations. The Company has initiated dosing in a Phase 2a/2b trial evaluating YB-101 in patients with GD, with or without concurrent TED.

Webull offers Yarrow Bioscience Inc stock information, including NASDAQ: YARW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YARW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading YARW stock methods without spending real money on the virtual paper trading platform.